Cited by 103Cancer therapeutics and mechanismsBioactive Compounds and Antitumor AgentsCancer-related Molecular Pathways

Mode of action of thiocoraline, a natural marine compound with anti-tumour activity

Open access
Erba, E, Bergamaschi, D, Ronzoni, S, Faretta, M, Taverna, S, Bonfanti, M, Catapano, C V, Faircloth, G +2 more·1999·British Journal of Cancer

Abstract

Thiocoraline, a new anticancer agent derived from the marine actinomycete Micromonospora marina, was found to induce profound perturbations of the cell cycle. On both LoVo and SW620 human colon cancer cell lines, thiocoraline caused an arrest in G1 phase of the cell cycle and a decrease in the rate of S phase progression towards G2/M phases, as assessed by using bromodeoxyuridine/DNA biparametric flow cytometric analysis. Thiocoraline does not inhibit DNA-topoisomerase II enzymes in vitro, nor does it induce DNA breakage in cells exposed to effective drug concentrations. The cell cycle effects observed after exposure to thiocoraline appear related to the inhibition of DNA replication. By using a primer extension assay it was found that thiocoraline inhibited DNA elongation by DNA polymerase alpha at concentrations that inhibited cell cycle progression and clonogenicity. These studies indicate that the new anticancer drug thiocoraline probably acts by inhibiting DNA polymerase alpha activity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjc.6690451

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Erba, E., Bergamaschi, D., Ronzoni, S., Faretta, M., Taverna, S., Bonfanti, M., Catapano, C. V., Faircloth, G., Jimeno, J., & D’Incalci, M.
Affiliations
  • Mario Negri Institute for Pharmacological Research (IT)
  • Medical University of South Carolina (US)
  • PharmaMar (Spain) (ES)
Venue
British Journal of Cancer
Published
1999-05-07
Volume
80
Issue
7
Pages
971-980
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2052430670
Cited by
103
References
13
Citations by year
2026: 5 · 2025: 4 · 2024: 6 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 5 · 2017: 3 · 2016: 7 · 2015: 8 · 2014: 5 · 2013: 6 · 2012: 5
FWCI
0.34
Type
journal article
Language
en
Open access
Locations
  • British Journal of Cancer (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by-nc-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
marine actinomycetes, anticancer agents, cell cycle arrest, G1 cell cycle arrest, DNA replication inhibition, DNA polymerase alpha, colon cancer, mechanism of action, topoisomerase II
MeSH terms
Anti-Bacterial Agents, Antibiotics, Antineoplastic, Bromodeoxyuridine, Cell Cycle, Cell Division, DNA, DNA-Directed DNA Polymerase, Flow Cytometry, Humans, Peptides, Time Factors, Tumor Cells, Cultured, Tumor Stem Cell Assay, Inhibitory Concentration 50, Depsipeptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review